Shuhei Sekiguchi

Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients

M. Kurosaki, N. Izumi, H. Nakanishi, 2021, Journal of gastroenterology and hepatology.

Risk difference of liver-related and cardiovascular events by liver fibrosis status in nonalcoholic fatty liver disease.

M. Kurosaki, N. Izumi, H. Nakanishi, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy

M. Kurosaki, N. Izumi, Y. Asahina, 2022, Cancer reports.

Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan

N. Enomoto, M. Kurosaki, N. Izumi, 2021, Digestive Diseases.

Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease

M. Kurosaki, N. Izumi, H. Nakanishi, 2021, Journal of gastroenterology and hepatology.

Changes of liver stiffness measured by magnetic resonance elastography during direct‐acting antivirals treatment in patients with chronic hepatitis C

N. Enomoto, M. Kurosaki, N. Izumi, 2020, Journal of medical virology.

The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy

M. Kurosaki, N. Izumi, H. Nakanishi, 2022, PloS one.

Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib

M. Kurosaki, N. Izumi, H. Nakanishi, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis

M. Kurosaki, N. Izumi, H. Nakanishi, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib

M. Kurosaki, N. Izumi, H. Nakanishi, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog

M. Kurosaki, N. Izumi, H. Nakanishi, 2020, Journal of gastroenterology and hepatology.

Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy

M. Kurosaki, N. Izumi, Takamasa Noda, 2020, Scientific Reports.

Prognosis of intrahepatic cholangiocarcinoma stratified by albumin–bilirubin grade

M. Kurosaki, N. Izumi, H. Nakanishi, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.